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Background: Previous studies suggest that disease activity alone does not reliably predict hospital readmission among patients with inflammatory
bowel diseases (IBDs). Using a national database, we aimed to further describe the burden of readmissions for IBD and identify modifiable risk factors.
Methods: We performed a retrospective cohort study using 2013 data from the Nationwide Readmission Database (NRD). Using International
Classification of Diseases, ninth Revision, Clinical Modification (ICD-9-CM) codes, we identified adult patients with discharge diagnoses of ulcerative
colitis or Crohn’s disease and ascertained diagnoses of anxiety, depression, chronic pain, tobacco use, and other comorbidities during index admission.
Logistic regression was used to estimate factors associated with hospital readmission.
Results: Among 52,498 hospitalizations of patients with IBD (63% Crohn’s disease and 37% ulcerative colitis), 12,407 (24%) were readmitted within
90 days of the index hospitalization, resulting in roughly $576 million in excess charges. In multivariable analysis of patients with Crohn’s disease,
anxiety (odds ratio [OR] 1.31, 95% confidence interval [CI], 1.21–1.43), depression (OR 1.27, 95% CI, 1.07–1.50), chronic pain (OR 1.31, 95% CI,
1.18–1.46), and tobacco abuse (OR 1.13, 95% CI, 1.06–1.22) were associated with a significant increase in odds of readmission. Among patients with
ulcerative colitis, anxiety (OR 1.28, 95% CI, 1.14–1.45), depression (OR 1.35, 95% CI, 1.07–1.70), and chronic pain (OR 1.44, 95% CI, 1.21–1.73) were
associated with a significant increase in odds of readmission.
Conclusions: Readmission occurs frequently in patients with IBD and is costly. Anxiety, depression, and chronic pain may represent targets for
interventions to prevent 90-day hospital readmission in this population.
(Inflamm Bowel Dis 2017;23:875–881)
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H ospital readmissions are a key metric associated with qualityof health care in the United States (US).1 Furthermore, hos-
pital readmissions place a great burden on the health care system
and patients.1 In the US, an estimated 1.2 to 1.4 million patients
have chronic inflammatory bowel disease (IBD); including both
ulcerative colitis (UC) and Crohn’s disease (CD).2,3 These disor-
ders are characterized by recurring gastrointestinal symptoms
often requiring gastrointestinal procedures, intravenous fluid and
medication support, hospitalization, and/or surgery. Thus, those
with IBD represent a significant portion of patients with gastro-
intestinal disorders who are hospitalized.4
Many studies evaluating readmissions in IBD have been
focused on the identification of factors associated with readmis-
sion in the postoperative period, including the need for emergent
surgery during the index admission and preoperative
comorbidities.5–8 The existing literature on IBD readmissions
after nonsurgical hospitalizations in the US includes single-
center experiences, where generalizability may be limited. How-
ever, these studies have suggested that poorly controlled pain and
depression,9 and lack of compliance with outpatient follow-up4
were associated with a higher likelihood of readmission. Previous
work has also demonstrated that disease activity was not related to
readmission within 90 days,9 suggesting the role of other, poten-
tially modifiable factors, such as psychiatric disease, tobacco
abuse, and chronic pain.
To date, there has not been an assessment of national data
to assess the factors associated with readmission in patients with
IBD. Our objective was to use the Nationwide Readmissions
Database (NRD) to describe the overall disease burden of
readmission in patients with IBD and analyze the factors
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of the Charlson comorbidity index, which has been validated for
use as a marker of comorbid illness in studies using large admin-
istrative databases.11 Given our specific interest in the role that
modifiable risk factors such as depression (ICD-9-CM 296.2,
296.3, 298.0, 300.4, 311), chronic pain (338.2 or 338.4), tobacco
abuse (305.1), and anxiety (300, 300.2) play in readmission we
made the a priori decision to include these covariates in our
analyses. For the definition of anxiety and depression, we used
ICD-9-CM definitions that have previously been validated in IBD
using administrative data.12 Similarly, we used diagnosis coding
for Clostridium difficile infection (CDI) that has previously been
used in HCUP databases.13 All ICD-9-CM codes used in our
analyses are detailed in the Supplementary Table, Supplemental
Digital Content 1, http://links.lww.com/IBD/B497.
We also evaluated hospital-specific factors including hos-
pital location/teaching status, as well as IBD-related hospital
volume. For the evaluation of IBD-related hospital volume, we
used previously identified cutoffs from the Nationwide Inpatient
Sample (NIS) of low, medium, and high centers (#50 admissions
annually, 51–150, and.150 admissions, respectively).14 Because
of high correlation between location/teaching status and hospital
volume, only hospital location/teaching status was included in our
final models. IBD-related surgery was included in the models for
CD but not UC, given that patients with UC undergoing colec-
tomy could have a scheduled readmission for repeat operation
within the 90-day follow-up for readmission, with the ultimate
plan for ileal pouch–anal anastomosis or other pouch operation.
Statistical Analysis
All analyses were performed using survey procedures in
SAS version 9.4 (SAS Institute, Cary, NC) to account for the
complex survey design. Data were weighted to reflect estimates of
the national population, including the mean and proportions
presented. Chi-square test and Student’s t test were used to com-
pare proportions and continuous variables, respectively. We used
logistic regression modeling to estimate the unadjusted odds of
a readmission within 90 days of the index hospitalization for the
covariates of interest. Based on clinical knowledge and previously
reported risk factors for readmission, multivariable logistic regres-
sion models were then constructed to evaluate the association
between risk factors and readmission within 90 days, adjusting
for potential confounders. All factors were included in the model
because of their clinical relevance, including payer and hospital-
specific factors, and all factors included in the final models were
identified a priori. A 2-tailed P-value of 0.05 was chosen as the
threshold for statistical significance for all tests. Odds ratios (ORs)
and 95% confidence intervals (CIs) are presented.
RESULTS
Among 52,498 patients with a diagnosis of IBD in the NRD
(63% CD and 37% UC), 12,407 (24%) required readmission
within 90 days of their index hospitalization. In univariate
analysis, patients requiring readmission were younger, had higher
associated with hospital readmission within 90 days, with 




We conducted a retrospective cohort study using 2013 data 
from the NRD, a resource of the Healthcare Cost and Utilization 
Project (HCUP) State Inpatient Databases. The NRD is a publicly 
available all-payer inpatient database from the US that includes 
data from 14,325,172 hospitalizations. Using data from 21 states, 
the NRD is designed to be nationally representative of readmis-
sion rates for all payers and the uninsured. The NRD contains 
more than 100 clinical and nonclinical variables,10 up to 15 diag-
nostic and procedure codes based on International Classification 
of Diseases, ninth Revision, Clinical Modification (ICD-9-CM) 
coding, hospital characteristics, and outcomes, including hospital 
length of stay (LOS), readmission, and total charges. Because of 
the deidentified nature of the data, this study was determined 
exempt from review by the University of North Carolina Institu-
tional Review Board.
Study Sample
We examined discharge data from patients age 18 years and 
older. Any patient with an ICD-9-CM diagnosis code indicating 
CD (555.xx) or UC (556.xx) was eligible for inclusion in this 
study. To minimize misclassification of subgroups of IBD (CD 
or UC), we excluded patients with discharge codes for both CD 
and UC (n ¼ 557). The index admission was defined as the first 
admission where an ICD-9-CM diagnosis code for CD or UC was 
recorded as one of the first 3 diagnosis codes. Given our interest in 
evaluating 90-day readmissions, only those patients with a full 90 
days between the date of discharge from their index admission 
and December 31, 2013 were included in these analyses.
Outcomes of Interest
The primary outcome of interest, the first readmission 
within 90 days of the index hospitalization, was determined by 
linking discharge data of individual patients using a unique 
identifier specified within the NRD. We also evaluated the 
designated reason for readmission, as defined by the primary 
ICD-9-CM diagnosis code and the total charges and LOS associ-
ated with readmission.
Covariates
During the index admission, multiple covariates associated 
with a patient’s underlying IBD or perceived risk of readmission 
were evaluated. Patient demographics including age, sex, and 
primary insurance/payer for the index hospitalization were as-
sessed. ICD-9-CM diagnosis codes were used to identify addi-
tional clinical factors suggested to be independent predictors or 
confounders of the relationship between IBD and hospital read-
mission. These included the components of the Deyo modification
Charlson comorbidity index scores, were more likely to be
admitted to metropolitan teaching hospitals, and were more likely
to have Medicare or Medicaid insurance (Tables 1 and 2). In
addition, patients requiring hospital readmission were more likely
to have a diagnosis of anxiety, depression, chronic pain, tobacco
abuse, or CDI. Among patients with CD, those requiring read-
mission were more likely to have a diagnosis of a fistula (Table 1).
Readmission resulted in an additional 74,059 hospital days
for those affected. The median LOS for the first readmission for
patients with CD was 3.45 days (interquartile range: 1.93–6.07)
compared with a median LOS of 4.14 days (interquartile range:
2.40–7.03) for patients with UC (P ¼ 0.181). The 5 most frequent
primary diagnoses for readmissions among patients with CD were
CD (47%), intestinal obstruction (560.81, 560.89, 560.9, 1.7%)
septicemia (ICD-9-CM 038.9, 1.2%), anal and rectal abscess (566,
0.4%), and acute kidney failure (584.9, 0.3%). The 5 most fre-
quent primary diagnoses for readmissions among patients with
UC were UC (60%), septicemia (3%), intestinal obstruction
(1.4%), CDI (1.2%), and acute kidney failure (0.6%).
Among patients with IBD who were readmitted within 90
days, the median total charges for the first readmission were
$27,162 (interquartile range: $15,159–$50,606). The median total
charges for the first readmission for patients with UC were sig-
nificantly greater than patients with CD ($29,881 versus $25,862,
TABLE 1. Baseline Clinical and Demographic
Characteristics of Patients with CD in the 2013 NRD
No Readmission,
n ¼ 24,076 (%)
Readmission,
n ¼ 8267 (%) P
Age ,0.001
18–39 10,798 (45) 4040 (49)
40–59 7968 (33) 2634 (32)
$60 5002 (21) 1516 (18)
Female sex 13,370 (56) 4441 (54) 0.005
Anxiety 2678 (11) 1268 (15) ,0.001
Depression 592 (2) 285 (3) ,0.001
Tobacco abuse 4246 (17) 1805 (22) ,0.001
Chronic pain 1434 (6) 811 (10) ,0.001
Charlson comorbidity score ,0.001
#1 22,050 (92) 7397 (89)
2 1180 (5) 492 (6)
.2 846 (4) 378 (5)
Location and teaching status
of hospital
,0.001
Metropolitan nonteaching 9439 (39) 3075 (37)
Metropolitan teaching 12,830 (51) 4673 (57)
Rural 1807 (8) 519 (6)
Payer/insurance ,0.001
Medicare 5818 (24) 2392 (29)
Medicaid 3383 (14) 1807 (22)
Private insurance 11,657 (48) 2993 (36)
Self-pay 1833 (8) 618 (5)
No charge 292 (1) 95 (1)
Other 1072 (4) 346 (4)
CDI 479 (2) 249 (3) ,0.001
Need for IBD-related
surgery




#3 12,370 (51) 3599 (44)
4–7 8050 (33) 2970 (36)
.7 3656 (15) 1698 (21)
Presence of a fistula (CD
only)
1464 (6) 643 (8) ,0.001
Small bowel obstruction
(CD only)
10,608 (18) 3572 (17) 0.534
TABLE 2. Baseline Clinical and Demographic
Characteristics of Patients with UC in the 2013 NRD
No Readmission,
n ¼ 16,015 (%)
Readmission,
n ¼ 4140 (%) P
Age 0.002
18–39 5787 (36) 1584 (38)
40–59 5044 (31) 1199 (29)
$60 4990 (31) 1297 (31)
Female sex 8441 (53) 2069 (50) 0.004
Anxiety 1508 (9) 501 (12) ,0.001
Depression 368 (2) 110 (3) 0.023
Tobacco abuse 1388 (9) 330 (8) 0.178
Chronic pain 606 (4) 229 (6) ,0.001
Charlson comorbidity score ,0.001
#1 13,847 (86) 3489 (84)
2 1116 (7) 347 (7)
.2 1052 (7) 344 (8)
Location and teaching status
of hospital
,0.001
Metropolitan nonteaching 6409 (40) 1499 (36)
Metropolitan teaching 8583 (54) 2432 (59)
Rural 1023 (6) 209 (5)
Payer/insurance ,0.001
Medicare 4402 (27) 1224 (30)
Medicaid 1899 (12) 678 (16)
Private insurance 7614 (48) 1771 (43)
Self-pay 1081 (7) 203 (5)
No charge 168 (1) 41 (1)
Other 827 (5) 223 (5)




#3 7108 (44) 1425 (34)
4–7 5830 (36) 1665 (40)
.7 3077 (19) 1050 (25)
Previous single-center studies have associated an increased
risk of hospital readmission with factors such as chronic pain and
depression.9 Abdominal pain is a common symptom among pa-
tients with IBD15 and may be associated with IBD-irritable bowel
syndrome.16,17 Although there were no available data on medica-
tion use within the NRD, a previous study evaluating narcotic
pain use among inpatients with IBD demonstrated that use of
narcotic pain medications was not associated with disease sever-
ity.18 Among patients with IBD, chronic pain has been associated
with significant effects on quality of life, as well as functional and
social outcomes.19
TABLE 3. Unadjusted and Adjusted Analyses, Odds of






18–39 1.14 (1.07–1.22) 1.18 (1.11–1.26)
40–59 Reference Reference
.59 0.94 (0.86–1.01) 0.78 (0.71–0.86)
Female sex 0.93 (0.88–0.98) 0.87 (0.82–0.92)
Anxiety 1.51 (1.39–1.63) 1.31 (1.21–1.43)
Depression 1.53 (1.30–1.79) 1.27 (1.07–1.50)
Tobacco abuse 1.30 (1.21–1.39) 1.13 (1.06–1.22)
Chronic pain 1.69 (1.53–1.87) 1.31 (1.18–1.46)
Charlson comorbidity score
#1 Reference Reference
2 1.25 (1.11–1.41) 1.17 (1.03–1.33)
.2 1.38 (1.21–1.58) 1.30 (1.12–1.51)
Location and teaching status of
hospital
Metropolitan nonteaching 0.87 (0.83–0.92) 0.88 (0.83–0.93)
Metropolitan teaching Reference Reference
Rural 0.77 (0.69–0.85) 0.75 (0.67–0.84)
Payer/insurance
Medicare 1.57 (1.47–1.68) 1.64 (1.50–1.78)
Medicaid 2.05 (1.90–2.21) 1.79 (1.66–1.94)
Private insurance Reference Reference
Self-pay 1.25 (1.12–1.39) 1.13 (1.02–1.27)
No charge 1.36 (1.03–1.78) 1.17 (0.89–1.55)
Other 1.12 (0.98–1.29) 1.07 (0.93–1.23)
CDI 1.70 (1.44–2.02) 1.47 (1.23–1.75)
Need for IBD-related surgery 0.67 (0.61–0.73) 0.56 (0.51–0.61)
LOS for index hospitalization,
d
#3 Reference Reference
4–7 1.27 (1.19–1.35) 1.31 (1.23–1.40)
.7 1.56 (1.44–1.68) 1.62 (1.49–1.77)
Presence of a fistula 1.32 (1.18–1.46) 1.42 (1.26–1.59)
All variables included in the final multivariable analysis are listed above.
P ¼ 0.019). When aggregated among all IBD patients in the 
NRD, the total charges attributed to the first readmission within 
90 days were $576,702,174.
Factors Associated with Readmission in CD
Several factors were associated with readmission within 90 
days among patients with CD, in both unadjusted and adjusted 
analysis. In multivariable analysis, anxiety (OR 1.18, 95% CI, 
1.11–1.26), depression (OR 1.27, 95% CI, 1.07–1.50), chronic 
pain (OR 1.31, 95% CI, 1.18–1.46), and tobacco abuse (OR 
1.13, 95% CI, 1.06–1.22) were associated with a significant 
increase in odds of readmission within 90 days of index hospital-
ization (Table 3). In addition, younger age, diagnosis of a fistula, 
higher Charlson comorbidity scores, CDI, Medicare and Medicaid 
insurance status or self-pay status, and an LOS greater than 3 days 
on the index admission all were associated with increased odds of 
readmission within 90 days (Table 3). An IBD-related surgery 
during the index admission was associated with decreased odds 
of readmission within 90 days (OR 0.56, 95% CI, 0.51–0.61). 
When evaluating hospital-related factors, patients admitted to 
a rural (OR 0.75, 95% CI, 0.67–0.84) or a metropolitan nonteach-
ing hospital (0.88, 95% CI, 0.83–0.93) were less likely to be 
readmitted when compared with patients admitted to metropolitan 
teaching hospitals.
Factors Associated with Readmission in UC
When patients with UC were evaluated in multivariable 
analysis, anxiety (OR 1.28, 95% CI, 1.14–1.45), depression 
(1.35, 95% CI, 1.07–1.70), and chronic pain (OR 1.44, 95%
CI, 1.21–1.73) were also associated with a significant increase 
in odds of readmission within 90 days of index hospitalization 
(Table 4). Younger age and LOS of greater than 3 days were 
associated with increased odds of readmission, as were Medi-
care and Medicaid insurance status, and higher Charlson comor-
bidity scores (Table 4). In addition, patients admitted to a rural 
or metropolitan nonteaching hospital were less likely to be re-
admitted when compared with patients admitted to metropolitan 
teaching hospitals (Table 4).
DISCUSSION
In a nationally representative database, we identified 
several potentially modifiable risk factors for readmission 
among patients with UC and CD, including concomitant 
diagnoses of anxiety, depression, or chronic pain conditions. 
Almost one-fourth of patients admitted with a diagnosis of IBD 
in the 2013 NRD were readmitted within 90 days of their index 
hospitalization. Additional risk factors for readmission include 
markers of more complex disease such as fistulizing disease 
among patients with CD and an increased LOS on the index 
admission. Insurance or payer status was also significantly 
associated with increased odds of readmission, with Medicare 
or Medicaid insurance being significantly associated with 
readmission among patients with both UC and CD.
Chronic abdominal pain involves dysregulation of the
brain–gut axis, which may lead to increased rates of anxiety
and depression.20 Both anxiety and depression are increased
among patients with IBD as compared to other disease states
and the general population.21–23 In addition, anxiety and
depression have been associated with an increased risk of
clinical recurrence of disease in patients with IBD,24 and higher
anxiety has been associated with increased resource utilization
among patients with IBD.25,26 Although the impact of these
psychological comorbidities has been identified in multiple
studies of patients with CD and UC, a majority of patients may
not be receiving adequate psychosocial support and services as
part of their overall care.27
There seems to be a significant opportunity for interven-
tions aimed at decreasing readmissions among patients with
psychosocial and chronic pain risk factors. In particular, early
recognition of patients with coexisting psychiatric disease and/or
chronic pain syndromes during the index admission is critical.
After recognition of these comorbidities, multidisciplinary ap-
proaches including the use of inpatient case management teams,
behavioral health consultations, and the integration of pain
management specialists into inpatient care models may lead to
better discharge planning. In addition, early identification of
responsible stakeholders after discharge including the patient’s
outpatient gastroenterologist, outpatient pain management spe-
cialists, and primary care provider may ultimately decrease read-
mission rates as well.
With 24% of patients requiring readmission within 90 days
of the index hospitalization, readmission represents a significant
burden to patients with IBD and the health care system overall.
Previous single-center experiences have reported 90-day readmis-
sion rates between 21% and 31% for patients with IBD.9,28
Although the demonstrated rate of readmission in this study was
similar, our use of a nationally representative sample is perhaps
a more accurate representation of the proportion of patients with
UC and CD requiring readmission within 90 days. In addition, our
findings are similar to the rate of readmission within 1 year reported
from an analysis using a Canadian national health database.29
The significant cost burden of hospital readmission has
previously been demonstrated by Hazratjee et al4 who found that
hospital readmissions within 30 days of index hospitalization
increased cost of care by 111%. We also demonstrated the sub-
stantial economic impacts of readmission. When aggregated
among all patients with IBD in the NRD, the total charges asso-
ciated with readmissions within 90 days were over $576 million.
In addition, those patients requiring readmission represented over
74,000 excess hospital days as compared to those patients who
did not require readmission.
When the reason for readmission has been evaluated in
earlier studies, recurrent UC or CD has been identified as the driver
of readmission in 27.8% to 31.4% of cases.4,9 Small bowel obstruc-
tion has been commonly associated with readmission among pa-
tients with CD in multiple studies4,9,30 and represented 1.7% of
readmissions among patients with CD in our population. The asso-
ciation between infectious complications and the need for readmis-
sion among patients with IBD is significant, particularly the
association between septicemia and both UC and CD readmissions.
In a previous study, patients with UC and sepsis demonstrated
a significantly higher mortality rate during hospitalization when
compared with a control population.31 In a separate study using
NIS, patients with IBD admitted to centers with a high annual
volume demonstrated lower in-hospital mortality.14 In a sensitivity
analysis in which hospital volume was included in our multivari-
able models, our final ORs were similar to those demonstrated in
the original models.
In our analysis, younger patients demonstrated increased
odds of readmission, whereas patients over 59 years of age
TABLE 4. Unadjusted and Adjusted Analyses, Odds of






18–39 1.18 (1.08–1.30) 1.24 (1.12–1.36)
39–59 Reference Reference
.59 1.10 (1.00–1.22) 0.98 (0.87–1.11)
Female sex 0.89 (0.82–0.96) 0.86 (0.79–0.93)
Anxiety 1.33 (1.18–1.50) 1.28 (1.14–1.45)
Depression 1.46 (1.17–1.84) 1.35 (1.07–1.70)
Tobacco abuse 0.82 (0.80–1.05) 0.92 (0.80–1.06)
Chronic pain 1.54 (1.0–1.83) 1.44 (1.21–1.73)
Charlson comorbidity score
#1 Reference Reference
2 1.18 (1.02–1.36) 1.12 (0.96–1.31)
.2 1.39 (1.21–1.60) 1.28 (1.10–1.48)
Location and teaching status of
hospital
Metropolitan nonteaching 0.79 (0.73–0.86) 0.82 (0.76–0.89)
Metropolitan teaching Reference Reference
Rural 0.66 (0.56–0.77) 0.69 (0.59–0.81)
Payer/insurance
Medicare 1.14 (1.04–1.25) 1.19 (1.09–1.35)
Medicaid 1.42 (1.27–1.59) 1.40 (1.25–1.57)
Private insurance Reference Reference
Self-pay 0.72 (0.61–0.85) 0.75 (0.63–0.90)
No charge 0.83 (0.58–1.20) 0.83 (0.57–1.20)
Other 1.07 (0.90–1.27) 1.04 (0.88–1.24)
CDI 1.17 (0.99–1.38) 1.03 (0.87–1.22)
LOS for index hospitalization,
d
#3 Reference Reference
4–7 1.41 (1.29–1.54) 1.39 (1.27–1.52)
.7 1.68 (1.52–1.86) 1.57 (1.42–1.74)
All variables included in the final multivariable analysis are listed above.
significant associations such as the decreased odds of readmission
among female patients.
The NRD also does not include information on race, which
is a significant limitation, as black race has been associated with
shorter time to readmission among pediatric patients34 and an
increased risk for readmission after colorectal surgery.35 Given
the structure of the NRD, we were also unable to evaluate pro-
vider factors that may have contributed to readmission, including
early discharge from the index hospitalization or treatment plans
that may have led to worse outcomes including readmission.
Although future approaches to decreasing readmission will likely
require multidisciplinary approaches, a continued focus on pro-
vider decision making during the hospitalization and discharge
planning will remain a key point in improving outcomes among
hospitalized patients with IBD.
In conclusion, within a nationally representative database, we
identified multiple risk factors for readmission among patients with
UC and CD that are associated with a significant increase in
charges. These include several potentially modifiable risk factors
including psychiatric disease and chronic pain conditions. Earlier
recognition of comorbid diagnoses of chronic pain, anxiety, and
depression, along with increased use of multidisciplinary teams and
care transition models, may lead to decreased hospital readmissions
and improved outcomes among patients with UC and CD.
REFERENCES
1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among pa-
tients in the medicare fee-for-service program. N Engl J Med. 2009;360:
1418–1428.
2. Kappelman MD, Moore KR, Allen JK, et al. Recent trends in the prev-
alence of Crohn’s disease and ulcerative colitis in a commercially insured
US population. Dig Dis Sci. 2013;58:519–525.
3. Long MD, Hutfless S, Kappelman MD, et al. Challenges in designing
a national surveillance program for inflammatory bowel disease in the
United States. Inflamm Bowel Dis. 2014;20:398–415.
4. Hazratjee N, Agito M, Lopez R, et al. Hospital readmissions in patients with
inflammatory bowel disease. Am J Gastroenterol. 2013;108:1024–1032.
5. Frolkis A, Kaplan GG, Patel AB, et al. Postoperative complications and
emergent readmission in children and adults with inflammatory bowel
disease who undergo intestinal resection: a population-based study. In-
flamm Bowel Dis. 2014;20:1316–1323.
6. Ozturk E, Kiran RP, Remzi F, et al. Early readmission after ileoanal pouch
surgery. Dis Colon Rectum 2009;52:1848–1853.
7. Medress Z, Fleshner PR. Can we predict unplanned hospital readmission
after colectomy for ulcerative colitis and indeterminate colitis? Am Surg.
2007;73:998–1001.
8. Sutton JM, Wima K, Wilson GC, et al. Factors associated with 30-day
readmission after restorative proctocolectomy with IPAA. Dis Colon Rec-
tum 2014;57:1371–1378.
9. Allegretti JR, Borges L, Lucci M, et al. Risk factors for rehospitalization
within 90 Days in patients with inflammatory bowel disease. Inflamm
Bowel Dis. 2015;21:2583–2589.
10. Agency for the Healthcare Cost and Resource Utilization Project. Intro-
duction to the HCUP Nationwide Readmission Database 2013. Available
at: https://www.hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2013.
jsp. Accessed January 9, 2017.
11. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index
for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;
45:613–619.
12. Marrie RA, Walker JR, Graff LA, et al. Performance of administrative
case definitions for depression and anxiety in inflammatory bowel disease.
J Psychosom Res. 2016;89:107–113.
demonstrated the lowest odds of readmission. An increased rate of 
hospitalizations and readmissions among younger patients with 
IBD has been demonstrated in other administrative databases as 
well.29,32 The increase in odds of readmission among younger 
patients is likely multifactorial, as patients may have a more 
severe disease course potentially associated with an earlier onset 
of IBD.32 In addition, older patients are likely to have other co-
morbidities, which might lead to increased follow-up with pri-
mary care or other providers after discharge from and index 
admission. These factors would not be captured in the NRD, 
however, and thus, we were not able to explore further.
Our study is the one of the first nationally representative 
study of hospital readmissions among patients with IBD. 
However, our study has inherent limitations that should be noted. 
The NRD does not include information regarding an individual 
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